Cannabis for the Treatment of Cancer: The Anticancer Activity of Phytocannabinoids and Endocannabinoids

Sixth Edition, February 2020: Yet more cases published in media, plus several new cases published in peer-reviewed journals, including a study that followed nine patients who used high doses of CBD for various brain tumors. The evidence is truly overwhelming and there is no humane argument to prevent patients from using cannabis medicine.

Fifth Edition, July 2018: Numerous more anecdotal cases published in media entities around the world.

Fourth Edition, October 2017: There are now over 100 reports of cannabis directly fighting cancer in humans. Many new reports from doctors themselves.

Third edition, March 2017: Many new testimonials added as well as analysis of the Phase II GW Pharmaceuticals trial showing how cannabinoids synergize with chemotherapy to fight cancer.

Second Edition, April 2016: Around a dozen new testimonials are included, most of them involving terminal cancers. The evidence continues to grow!

Cannabinoids like THC and CBD from the cannabis plant have been shown in scientific studies to fight brain, breast, cervical, cholangiocarcinoma, colon, leukemia, liver, lung, lymphoma, multiple myeloma, prostate, pancreatic, rhabdomyosarcoma, skin, and other cancers. They directly kill cancer cells as well as reduce proliferation, metastasis, and angiogenesis.

For the past several years, patients from across the world have reported cancer remissions by using high doses of cannabinoids. Doctors, dispensaries, corporations, and caregivers have also reported similar results. The evidence in this book undeniably demonstrates the anticancer effects of cannabis in humans, while also illuminating limits of the medicine and the importance of further research.